Literature DB >> 23628168

Computerized neuropsychological testing in epilepsy: overview of available tools.

Juri-Alexander Witt1, Willem Alpherts, Christoph Helmstaedter.   

Abstract

PURPOSE: Neuropsychology has become an essential diagnostic tool for epilepsy-related cognitive comorbidities and treatment evaluation. However, a lack of resources may prevent routine neuropsychological assessments outside specialized epilepsy centers. Computerized testing appears to offer a time- and cost-effective approach to assess cognitive functions in patients with epilepsy. Moreover, the technical advances of computerized tests provide interesting tools to address specific diagnostic questions around epilepsy. This review is intended: (1) to outline the advantages and disadvantages of computerized testing, (2) to delineate its indications and fields of application, and (3) to give an overview of available tools that have been applied in epilepsy or antiepileptic drug research.
METHOD: Iterative review of computer-based neuropsychological assessment batteries previously applied in clinical epileptological settings or antiepileptic drug trials.
RESULTS: Among nine reviewed computer tests merely three were explicitly devised for epilepsy and showed sensitivity to clinical parameters like focus lateralization or localization or the presence/absence of epileptiform activity. Concurrent validity with established measures was demonstrated for two of these three tests. Some sensitivity to antiepileptic pharmacotherapy was reported for seven of all nine reviewed test batteries.
CONCLUSION: Additional studies are needed to demonstrate the sensitivity and specificity of computerized neuropsychological tests to epilepsy and treatment related variables. In most clinical scenarios exclusive computerized testing cannot substitute a thorough neuropsychological examination in patients with epilepsy at present.
Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23628168     DOI: 10.1016/j.seizure.2013.04.004

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

1.  Weight of epilepsy in brain tumor patients.

Authors:  Marta Maschio; Francesca Sperati; Loredana Dinapoli; Antonello Vidiri; Alessandra Fabi; Andrea Pace; Alfredo Pompili; Carmine Maria Carapella; Tonino Cantelmi
Journal:  J Neurooncol       Date:  2014-05-01       Impact factor: 4.130

2.  Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam.

Authors:  Seong Hoon Kim; Sung-Chul Lim; Woojun Kim; Oh-Hun Kwon; Chan Mi Kim; Jong-Min Lee; Young-Min Shon
Journal:  Neuropsychiatr Dis Treat       Date:  2015-01-27       Impact factor: 2.570

3.  Computerized neuropsychological assessment in aging: testing efficacy and clinical ecology of different interfaces.

Authors:  Matteo Canini; Petronilla Battista; Pasquale Anthony Della Rosa; Eleonora Catricalà; Christian Salvatore; Maria Carla Gilardi; Isabella Castiglioni
Journal:  Comput Math Methods Med       Date:  2014-07-24       Impact factor: 2.238

Review 4.  Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review.

Authors:  Samuel Wilson; Benedetta Milanini; Shireen Javandel; Primrose Nyamayaro; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-25       Impact factor: 5.495

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.